Dual immune dysregulation in adolescent-onset schizophrenia: attenuated B cell trophic support and elevated IL-23/Th17 inflammation are diagnostic and clinical biomarkers
4 affiliations
- 1Department of Psychiatry, Lianyungang Psychiatric Hospital, The Fourth People’s Hospital of Lianyungang, The Affiliated Hospital of KangDa College of Nanjing Medical University, Lianyungang, 222003 China
- 2Xuzhou Medical University, Xuzhou, 221004 China
- 3The First Clinical Medical College of Xuzhou Medical University, Xuzhou, 221004 China
- 4Department of Psychiatry, The Affiliated Guangji Hospital of Soochow University, Suzhou, 215137 China
Abstract
Adolescent-onset schizophrenia (AOS) is marked by severe symptoms and cognitive impairments, yet its peripheral immune profile remains insufficiently characterized. This cross-sectional study aimed to develop composite immune pathway indices integrating serum B cell-activating factor (BAFF), a proliferation-inducing ligand (APRIL), interleukin (IL)-23, and IL-17 levels to reflect immune dysfunction. We examined 93 patients with first-episode, antipsychotic-naive AOS and 40 healthy controls. Five indices were constructed: immune homeostasis protection index (IHPI), BAFF-APRIL immune ratio (BAIR), immune drive-attenuation ratio (IDA), Th17 decoupling index (TDI), and full immune imbalance index (FIII). Serum BAFF (t = −3.324, P = 0.001) and APRIL (t = −3.687, P < 0.001) were significantly reduced and IL-23 was increased (Z = −2.777, P = 0.005), whereas IL-17 remained unchanged (P = 0.292) in patients with AOS. BAIR did not differ between groups (P = 0.741). IHPI was significantly reduced in patients with AOS (t = −5.203, P < 0.001), whereas IDA, TDI, and FIII were elevated (all P < 0.001). Serum IL-23 was independently associated with Positive and Negative Syndrome Scale total score (β = 0.321, P = 0.002) and general psychopathology subscale score (β = 0.320, P = 0.001). In healthy controls, serum BAFF predicted immediate memory (β = 0.408, P = 0.009) and Repeatable Battery for the Assessment of Neuropsychological Status total score (β = 0.444, P = 0.005), an association not observed in patients with AOS. Among composite indices, IHPI achieved the best discriminative performance (AUC = 0.751, sensitivity: 69.9%, and specificity: 72.5%), outperforming individual biomarkers. These findings indicated that dual peripheral immune dysregulation in AOS was characterized by attenuated B cell trophic support and upstream IL-23/Th17 activation, and suggested that composite immune indices may provide incremental diagnostic value over single cytokines.
Related
- Attenuated PER3 amplitude in hair follicles is associated with sleep irregularity in schizophrenia
- When “I” and “You” blur: self–other distinction failure and empathy dysregulation in schizophrenia
- Lipid Dysregulation and Impaired Resolution of Inflammation in Genetic Forms of Parkinson’s Disease: Potential Links and Knowledge Gaps
- Convergent Immunopathology in Influenza-Associated Encephalopathy: CD3+ CD4+ T Cell Depletion, IL-6-Mediated Inflammation, and Complement C3 Dysregulation
- Yiguanjian alleviates ocular surface inflammation and lacrimal gland immune dysregulation in experimental dry eye disease: evidence from in vivo and in vitro models
BibTeX
@article{yang2026dual,
title = {{Dual immune dysregulation in adolescent-onset schizophrenia: attenuated B cell trophic support and elevated IL-23/Th17 inflammation are diagnostic and clinical biomarkers}},
author = {Haidong Yang and Lingshu Luan and Yubing Han and Sijin Li and Man Yang and Xiaobin Zhang},
journal = {Translational Psychiatry},
year = {2026},
month = jul,
doi = {10.1038/s41398-026-04343-5},
url = {https://doi.org/10.1038/s41398-026-04343-5},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Dual immune dysregulation in adolescent-onset schizophrenia: attenuated B cell trophic support and elevated IL-23/Th17 inflammation are diagnostic and clinical biomarkers
AU - Haidong Yang
AU - Lingshu Luan
AU - Yubing Han
AU - Sijin Li
AU - Man Yang
AU - Xiaobin Zhang
PY - 2026
DA - 2026/07/30
JO - Translational Psychiatry
DO - 10.1038/s41398-026-04343-5
UR - https://doi.org/10.1038/s41398-026-04343-5
AB - Adolescent-onset schizophrenia (AOS) is marked by severe symptoms and cognitive impairments, yet its peripheral immune profile remains insufficiently characterized. This cross-sectional study aimed to develop composite immune pathway indices integrating serum B cell-activating factor (BAFF), a proliferation-inducing ligand (APRIL), interleukin (IL)-23, and IL-17 levels to reflect immune dysfunction. We examined 93 patients with first-episode, antipsychotic-naive AOS and 40 healthy controls. Five indices were constructed: immune homeostasis protection index (IHPI), BAFF-APRIL immune ratio (BAIR), immune drive-attenuation ratio (IDA), Th17 decoupling index (TDI), and full immune imbalance index (FIII). Serum BAFF (t = −3.324, P = 0.001) and APRIL (t = −3.687, P < 0.001) were significantly reduced and IL-23 was increased (Z = −2.777, P = 0.005), whereas IL-17 remained unchanged (P = 0.292) in patients with AOS. BAIR did not differ between groups (P = 0.741). IHPI was significantly reduced in patients with AOS (t = −5.203, P < 0.001), whereas IDA, TDI, and FIII were elevated (all P < 0.001). Serum IL-23 was independently associated with Positive and Negative Syndrome Scale total score (β = 0.321, P = 0.002) and general psychopathology subscale score (β = 0.320, P = 0.001). In healthy controls, serum BAFF predicted immediate memory (β = 0.408, P = 0.009) and Repeatable Battery for the Assessment of Neuropsychological Status total score (β = 0.444, P = 0.005), an association not observed in patients with AOS. Among composite indices, IHPI achieved the best discriminative performance (AUC = 0.751, sensitivity: 69.9%, and specificity: 72.5%), outperforming individual biomarkers. These findings indicated that dual peripheral immune dysregulation in AOS was characterized by attenuated B cell trophic support and upstream IL-23/Th17 activation, and suggested that composite immune indices may provide incremental diagnostic value over single cytokines.
SN - 2158-3188
ER -